Clinical Trials
3
Active:0
Completed:2
Trial Phases
3 Phases
Phase 2:1
Phase 3:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)ā¢ Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.
Phase 3
Completed
- Conditions
- Alopecia UniversalisAlopecia TotalisAlopecia Areata
- Interventions
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Jinnah Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06278402
- Locations
- šµš°
Misbah Zari Qadir, Karachi, Sindh, Pakistan
Effect of E-BAL on Severity of VAP Assessed Through CPIS on the Patients of Traumatic Brain Injury in Neurocritical Care, Also Effect on Days of Ventilation and ICU Stay.
Not Applicable
- Conditions
- Traumatic Brain InjuryVentilator Associated Pneumonia
- First Posted Date
- 2021-07-27
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Jinnah Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04977843
- Locations
- šµš°
Jinnah Hospital, Lahore, Punjab, Pakistan
Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients
Phase 2
Completed
- Conditions
- Corona Virus Infection
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Jinnah Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT04437823
- Locations
- šµš°
Jinnah Hospital, Lahore, Punjab, Pakistan
News
No news found